Clinical Trials Logo

Clinical Trial Summary

This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with cement augmentation is a useful approach for the treatment of secondary metastasis to the spine. Information collected in this study may help doctors to learn the effectiveness of this therapy, and may help to evaluate optimal technique, appropriate patient selection, and management of complications.


Clinical Trial Description

PRIMARY OBJECTIVE: I. To evaluate the use of radiofrequency ablation and cement augmentation for the treatment of secondary metastases to the spine. OUTLINE: Patients' medical data is collected retrospectively. ;


Study Design


Related Conditions & MeSH terms

  • Metastatic Malignant Neoplasm in the Spine
  • Neoplasms

NCT number NCT04751422
Study type Observational
Source M.D. Anderson Cancer Center
Contact
Status Recruiting
Phase
Start date November 13, 2020
Completion date September 30, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02387905 - Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases Phase 2
Recruiting NCT05178472 - Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria) N/A
Completed NCT02716948 - SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine Phase 1
Completed NCT02527304 - Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery N/A
Completed NCT03575949 - Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer N/A
Active, not recruiting NCT02364557 - Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival Phase 2/Phase 3
Completed NCT02713269 - Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord Phase 2